Stephanie has several years of experience in evidence synthesis and has worked as part of an Evidence Review Group for the National Institute for Health and Care Excellence (NICE) assessing single and multiple technology appraisals. She brings these ‘behind the scenes’ insights to help guide the development of robust, high quality systematic reviews for market access applications. Her expertise extends to epidemiology, treatment guidelines, burden of disease, efficacy and adverse events, meta-analysis, statistical reviewing, shared decision-making and more.
Stephanie has spent over 12 years as an academic research scientist working across in vitro, pre-clinical, and clinical projects. In Canada, she worked for several years developing live viral vaccines for Phase I trials and running immunological assays on clinical trial samples. She has also worked as a freelance science writer preparing research excellence framework submissions to assess the quality of research in UK higher education institutes, UNICEF annual reports to analyse research impact, and academic manuscripts. She is a member of the Association of British Science Writers.
Stephanie maintains a strong research interest in cancer, immunotherapy, viruses, immunology, genomics, personalised medicine, and gene therapy to support evidence generation in cutting-edge technologies. She has a PhD in Molecular Virology from the University of York.